Hanne Røland Hagland
Førsteamanuensis i biokjemi
Kontakt
Telefon: 51831242
E-post: hanne.r.hagland@uis.no
Rom: I8 D-112
Sted: Måltidets og Havets hus, Innovasjonsparken I8
Organisasjonsenhet
Det teknisk-naturvitenskapelige fakultet
Institutt for kjemi, biovitenskap og miljøteknologi
Kort om meg
My research interest area is cancer cell metabolism. Cancer cells can be highly hetereogenous with regards to DNA mutations and gene expression, but still have a common ability to adapt and grow in challenging tumour growth environments. We are interested in studying the mitochondrial contribution to growth adaptation in cancer cells and how this influence cancer treatment response. We are working in close collaboration with clinicians in the field of translational oncology, adapting protocols to real patient samples to give more targeted treatment to cancer patients. Our lab facilities entails state of the art equipment for studying mitochondrial oxidative capacity in various cell models, as well as gene and protein expressions.
In our lab we currently have two 3D bioprinters and regular 3D printers to support our research with regards to extracellular matrix design with more advanced cell models (organoids, tumour spheroids) in our study of mitochondrial fitness in cancer. I am always interested in new collaborations and thrive in learning about new technologies to see how they can be used in our research to better understand and tailor treatments for cancer disease.
Dette forsker jeg på
My research interest area is cancer cell metabolism. Cancer cells can be highly hetereogenous with regards to DNA mutations and gene expression, but still have a common ability to adapt and grow in challenging tumour growth environments. We are interested in studying the mitochondrial contribution to growth adaptation in cancer cells and how this influence cancer treatment response. We are working in close collaboration with clinicians at Stavanger University Hospital in the field of translational oncology, adapting protocols to real patient samples to give more targeted treatment to cancer patients. Our lab facilities entails state of the art equipment for studying mitochondrial oxidative capacity in various cell models, as well as gene and protein expressions.
In our lab we currently have two 3D bioprinters and regular 3D printers to support our research with regards to extracellular matrix design with more advanced cell models (organoids, tumour spheroids) in our study of mitochondrial fitness in cancer. I am always interested in new collaborations and thrive in learning about new technologies to see how they can be used in our research to better understand and tailor treatments for cancer disease.
Akademisk bakgrunn
My background is in molecular genetics in biotechnology from my undergraduate levels performed at Sussex University in Brighton, UK. I then continued with more biomedical direction with my MSc in Medical cell biology at the University of Bergen, where I also in 2012 completed my PhD in mitochondrial flexibility in cancer. I worked at Stavanger University Hospital after my PhD together with the gastrointestinal surgery research group, led by Professor Søreide, to assist in establishing two large biobanks currently running at the hospital. Since 2015 I have been employed as an associate professor in Biomedicine at the University of Stavanger building my own research group in collaboration with the good colleagues at the hospital. Currently, I teach first year cell biology and a graduate course in advanced cell biology at the BSc/MSc programmes in biological chemistry at the department of chemistry, biosciences and environmental engineering. I welcome and host projects for both BSc and MSc students from our programme as well as supervise PhD students within my field of research.